220 related articles for article (PubMed ID: 21700700)
1. Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine.
Bedia C; Casas J; Andrieu-Abadie N; Fabriàs G; Levade T
J Biol Chem; 2011 Aug; 286(32):28200-9. PubMed ID: 21700700
[TBL] [Abstract][Full Text] [Related]
2. Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells.
Risberg K; Fodstad O; Andersson Y
J Immunother; 2010 Apr; 33(3):272-8. PubMed ID: 20445347
[TBL] [Abstract][Full Text] [Related]
3. Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
Hardy KM; Strizzi L; Margaryan NV; Gupta K; Murphy GF; Scolyer RA; Hendrix MJ
Mol Cancer Res; 2015 Apr; 13(4):670-80. PubMed ID: 25767211
[TBL] [Abstract][Full Text] [Related]
4. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
Mizutani N; Inoue M; Omori Y; Ito H; Tamiya-Koizumi K; Takagi A; Kojima T; Nakamura M; Iwaki S; Nakatochi M; Suzuki M; Nozawa Y; Murate T
J Biochem; 2015 Oct; 158(4):309-19. PubMed ID: 25888580
[TBL] [Abstract][Full Text] [Related]
5. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
6. Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expression.
Lucki NC; Sewer MB
J Biol Chem; 2011 Jun; 286(22):19399-409. PubMed ID: 21493710
[TBL] [Abstract][Full Text] [Related]
7. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Serrone L; Zeuli M; Sega FM; Cognetti F
J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
[TBL] [Abstract][Full Text] [Related]
8. Metformin pretreatment reduces effect to dacarbazine and suppresses melanoma cell resistance.
Sanches LJ; Marinello PC; da Silva Brito WA; Lopes NMD; Luiz RC; Cecchini R; Cecchini AL
Cell Biol Int; 2022 Jan; 46(1):73-82. PubMed ID: 34506671
[TBL] [Abstract][Full Text] [Related]
9. Analysis of O(6)-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy.
Ma S; Egyházi S; Martenhed G; Ringborg U; Hansson J
Melanoma Res; 2002 Aug; 12(4):335-42. PubMed ID: 12170182
[TBL] [Abstract][Full Text] [Related]
10. Tyrosinase overexpression promotes ATM-dependent p53 phosphorylation by quercetin and sensitizes melanoma cells to dacarbazine.
Thangasamy T; Sittadjody S; Limesand KH; Burd R
Cell Oncol; 2008; 30(5):371-87. PubMed ID: 18791269
[TBL] [Abstract][Full Text] [Related]
11. Combined Therapy with Dacarbazine and Hyperthermia Induces Cytotoxicity in A375 and MNT-1 Melanoma Cells.
Salvador D; Bastos V; Oliveira H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408947
[TBL] [Abstract][Full Text] [Related]
12. Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
Lev DC; Ruiz M; Mills L; McGary EC; Price JE; Bar-Eli M
Mol Cancer Ther; 2003 Aug; 2(8):753-63. PubMed ID: 12939465
[TBL] [Abstract][Full Text] [Related]
13. New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance.
Spiro T; Liu L; Gerson S
Forum (Genova); 2000; 10(3):274-85. PubMed ID: 11007934
[TBL] [Abstract][Full Text] [Related]
14. [Hypersensitivity to dacarbazine in patients with metastatic malignant melanoma].
Levy A; Guitera P; Kerob D; Ollivaud L; Archimbaud A; Dubertret L; Basset-Seguin N
Ann Dermatol Venereol; 2006 Feb; 133(2):157-60. PubMed ID: 16508601
[TBL] [Abstract][Full Text] [Related]
15. Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells.
Engesæter BO; Sathermugathevan M; Hellenes T; Engebråten O; Holm R; Flørenes VA; Mælandsmo GM
Cancer Biol Ther; 2011 Jul; 12(1):47-58. PubMed ID: 21508672
[TBL] [Abstract][Full Text] [Related]
16. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity.
Ding B; Wu X; Fan W; Wu Z; Gao J; Zhang W; Ma L; Xiang W; Zhu Q; Liu J; Ding X; Gao S
Int J Nanomedicine; 2011; 6():1991-2005. PubMed ID: 21976975
[TBL] [Abstract][Full Text] [Related]
17. Acid ceramidase controls apoptosis and increases autophagy in human melanoma cells treated with doxorubicin.
Lai M; Amato R; La Rocca V; Bilgin M; Freer G; Spezia P; Quaranta P; Piomelli D; Pistello M
Sci Rep; 2021 May; 11(1):11221. PubMed ID: 34045496
[TBL] [Abstract][Full Text] [Related]
18. The curcumin analog DM-1 induces apoptotic cell death in melanoma.
Faião-Flores F; Suarez JA; Maria-Engler SS; Soto-Cerrato V; Pérez-Tomás R; Maria DA
Tumour Biol; 2013 Apr; 34(2):1119-29. PubMed ID: 23359272
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.
Zheng M; Bocangel D; Ramesh R; Ekmekcioglu S; Poindexter N; Grimm EA; Chada S
Mol Cancer Ther; 2008 Dec; 7(12):3842-51. PubMed ID: 19056673
[TBL] [Abstract][Full Text] [Related]
20. Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis.
Valero T; Steele S; Neumüller K; Bracher A; Niederleithner H; Pehamberger H; Petzelbauer P; Loewe R
J Invest Dermatol; 2010 Apr; 130(4):1087-94. PubMed ID: 19940857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
